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Abstract
Background: In China, the middle esophageal squamous cell cancer is the most common tumor type, and
Mckeown esophagectomy (ME) is preferably adopted by thoracic surgeon. But, the surgical trauma of ME is
great. Thoracolaparoscopic esophagectomy (TE) was developed to decrease the operative stress; however, the
safety and efficacy were not defined. In this study, clinical outcomes were compared between patients who
received ME and TE.
Methods: The data of 113 patients who suffered from middle-thoracic esophageal cancer during the same
period were collected. Sixty-two patients received ME (ME group), and 51 patients received TE (TE group).
Patients’ demographics and short-term clinicopathologic outcomes were comparable between the two
groups. Survival rate was estimated using the Kaplan–Meier method, and comparisons between groups were
performed with log–rank test.
Results: Patients in TE group had lower body mass index (BMI). Preoperative tumor stage in TE group was
much earlier. Both overall and thoracic operation time were longer in TE group. The blood loss during
operation and postoperative day (POD) 1 was less in TE group, which contributed to the less blood
transfusion. In TE group, postoperative incidence of pulmonary complications and atrial fibrillation (p = 0.035
and p = 0.033) was lower; the inflammatory response and incision pain were significantly alleviated; the ICU
and in-hospital stay was shorter as well because of less surgical trauma. No statistically significant difference
was found between two groups in terms of overall survival or disease-free survival.
Conclusions: The efficacy and safety of TE were supported by the selected patients in this cohort study.
Although it is lack of randomness in this research, some advantages of TE were gratifying such as lower
postoperative complications and similar survival with ME. A multicenter prospective randomized study is
now required.
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Background
Compared with developed countries, in China, the squa-
mous carcinoma in the middle of esophagus as the pre-
dominant esophageal cancer (EC) type has led many
groups to advocate the thoracolaparoscopic surgical ap-
proach with intra-thoracic or cervical anastomosis as the
operation of choice for these cancers [1, 2]. Before appli-
cation thoracolaparoscopic surgical approach, McKeown
and Ivor Lewis approaches were used by our depart-
ment. Compared with left transthoracic approach (one
incision in left thorax), combined transabdominal and
transthoracic approach was regarded as the optimal
strategy for cancer clearance and two-field lymphade-
nectomy [3–5].
The McKeown approach is thought with numerous
advantages over other approaches for middle EC. Poten-
tial advantages of the McKeown approach compared to
the Ivor Lewis include less chance of local recurrence,
anastomosis in neck easier to manage if leak occurs, and
less need to expand the thoracic incision since the anas-
tomosis is in the neck instead of the chest [6]. Despite
advances in surgical techniques, anesthetic techniques,
and perioperative care, morbidity and mortality rates
of McKeown or Ivor Lewis approach are consistently
high. The most important cause of significant morbid-
ity and mortality after open approaches for EC is the
development of cardiac [7, 8] and pulmonary compli-
cations [9–11].
In order to reduce the surgical trauma and the
postoperative cardiopulmonary complication, minimal
invasive thoracolaparoscopic esophagectomy with cer-
vical gastroesophageal anastomosis was performed in
our department from 2010. In this study, we reported
the clinical outcomes of 51 patients undergoing thor-
acolaparoscopic esophagectomy with cervical gastro-
esophageal anastomosis compared with 62 patients
undergoing McKeown esophagectomy at the same
period. The efficacy and safety of thoracolaparoscopic
esophagectomy (TE) would be testified by this study,
which could offer theoretical foundation for its clin-
ical application.
Methods
Patients and grouping: from 2010 to 2013, retrospective
data of 113 patients with middle esophageal squamous
cancer underwent conventional Mckeown esophagec-
tomy (ME) (n = 62) or TE (n = 51) at Nantong First
People’s Hospital were collected. All patients took rou-
tine examinations such as blood routine test, blood gas
analysis, electrocardiogram, C-response protein, barium
swallow, endoscopic ultrasonography for esophagus and
stomach with biopsy, and chest and abdominal com-
puted tomography. All patients were discussed at a
multidisciplinary specialist team meeting. This study was
approved by the ethics committee in Nantong first peo-
ple’s hospital. The informed consent was obtained from
each patient. Then, the standard staging was performed
according to local protocols. There was no significant
difference in the prevalence of tumor stages in between
two groups (showed in Table 1). The histo-pathological
types of all patients were squamous cell cancer (Fig. 1c).
All operations were mainly performed by surgeon Zhong
CJ. Patients with lower BMI and earlier preoperative
tumor stage were preferably selected for TE at the
beginning of this technique. ME was recommended for
patients with higher BMI and advanced tumor stage. No
patient received adjuvant therapy before surgery.
Data collected included demographics, overall and
thoracic operative times, blood loss during operation
and postoperative day (POD) 1, blood transfusion, in-
tensive care unit stay, in-hospital stay, pre- and post-
operative tumor node metastasis (TNM) [12] stage
analysis, and mortality. Postoperative complications
were graded according to the Clavien–Dindo classifi-
cation [13]. Clavien–Dindo grades I and II represent
minor complications, whereas grades III and IV rep-
resent major complications [13]. An anastomotic leak
(AL) was confirmed by radiology (CT scan or iodine
oil contrast esophagography under DSA), endoscopy,
or during surgical exploration. The body temperature,
heart rate, respiratory rate, white blood cell, C-reactive
protein, and incision pain on pre- and postoperative
day, POD 1, 3, and 5, were recorded. Numerical rat-
ing scales (NRSs) used to assess pain intensity [14].
Patients were routinely followed up for 5 years post-
operation according to the following protocol: 1
monthly for 6 months, 3 monthly for 1 year, 6
monthly for 2 years, and yearly thereafter. Recurrence
of cancer during follow-up included the first site
(anastomosis site), distant organs, local lymph nodes,
and distant lymph nodes recurrence.
Surgical techniques
In ME group, the procedure was the same as described
by Siegel et al. [15], in brief, which include thoracic
esophageal mobilization through the right fifth or sixth
thoracotomy; thoracic lymph node dissection; ligation of
thoracic duct (not regularly performed in our depart-
ment if damaged); abdominal exploration; stomach
mobilization; abdominal lymph node dissection; used of
nose-duodenal nutritional tube instead of feeding jeju-
nostomy; left cervical incision for anastomosis.
In thoracolaparoscopic esophagectomy (TE) group, at
the first stage, all patients were kept in left lateral pos-
ition and leaning forward. This position obtained better
exposure of the posterior mediastinal tissue well by
pushing the right lung forward. General anesthesia was
performed with single-lumen intubation, which allowed
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moving trachea for better exposure of the lymph nodes
along the right and left recurrent pharyngeal nerve.
Four ports were made in the right chest wall after
single ventilation (Fig. 1a): one incision 12 mm in length
in the seventh intercostal axillary midline as the ob-
servation port for thoracoscope (Fig. 1a(1#); artificial
pneumothorax was performed, 8 mmHg); one oper-
ation ports about 3 mm in length in the third inter-
costal anterior axillary (Fig. 1a(2#)); the other two
operation ports were made eighth intercostal scapular
line (Fig. 1a(4#)) and fifth intercostal between poster-
ior axillary line and scapular line (Fig. 1a(3#)).
After confirming resectable of esophageal cancer,
ultrasonic knife and electrocantery were used to cut the
low pulmonary ligament and mediastinal pleura on the
surface of the esophagus. Arch of azygos vein was






Preoperative T stage <0.0001#
Tis 0 (0 %) 3 (5.9 %)
T1 5 (8.1 %) 15 (29.4 %)
T2 17 (27.4 %) 25 (49.0 %)
T3 38 (61.3 %) 8 (15.7 %)
T4 2 (3.2 %) 0 (0 %)
Preoperative N stage
N0 18 (29.0 %) 31 (60.8 %) 0.001*
N1 28 (45.2 %) 16 (31.4 %)
N2 11 (17.7 %) 4 (7.8 %)
N3 5 (8.1 %) 0 (0 %)
Preoperative M stage
M0 61 (98.4 %) 51 (100 %) 0.362
M1 1 (1.6 %) 0 (0 %)
Preoperative TNM stage 0.322
IA 5 (8.1 %) 9 (17.6 %)
IB 11 (17.7 %) 10 (19.6 %)
IIA 12 (19.4 %) 10 (19.6 %)
IIB 8 (12.9 %) 11 (21.6 %)
IIIA 16 (25.8 %) 8 (15.7 %)
IIIB 7 (11.3 %) 3 (5.9 %)
IIIC 2 (3.2 %) 0 (0 %)
IV 1 (1.6 %) 0 (0 %)
Postoperative T stage 0.001*
Tis 0 (0 %) 2 (3.9 %)
T1 11 (17.7 %) 11 (21.6 %)
T2 13 (21.0 %) 27 (52.9 %)
T3 37 (59.7 %) 11 (21.6 %)
T4 1 (1.6 %) 0 (0 %)
Postoperative N stage 0.270
N0 31 (50.0 %) 34 (66.7 %)
N1 16 (25.8 %) 11 (21.6 %)
N2 13 (21.0 %) 5 (9.8 %)
N3 2 (3.2 %) 1 (2.0 %)
Postoperative M Stage 0.196
M0 60 (96.8 %) 51 (100 %)
M1 2 (3.2 %) 0 (0 %)
Number of removed LN 15.3 ± 3.2 17.8 ± 3.6 0.0002*
Vessel cancer embolus 15 (24.2 %) 14 (27.5 %) 0.693
Nerve invasion 11 (17.7 %) 8 (15.7 %) 0.771
Median mD (mm) 31.3 ± 4.2 28.8 ± 3.4 0.001*
Table 1 Pre- and postoperative pathological characters
(Continued)
Morphology 0.711
Concealed 0 (0 %) 1 (2.0 %)
Erosive 1 (1.6 %) 2 (3.9 %)
Plaque 0 (0 %) 1 (2.0 %)
Polypoid 1 (1.6 %) 0 (0 %)
Medullary 26 (41.9 %) 18 (35.3 %)
Fungating 9 (14.5 %) 6 (11.8 %)
Ulcer 22 (35.5 %) 21 (41.2 %)
Constrictive 3 (4.8 %) 2 (3.9 %)
Differentiation 0.626
G1 6 (9.7 %) 4 (7.8 %)
G2 25 (40.3 %) 27 (52.9 %)
G3 28 (45.2 %) 18 (35.3 %)
G4 2 (3.2 %) 2 (3.9 %)
Gx 1 (1.6 %) 0 (0 %)
Postoperative TNM stage 0.197
IA 6 (9.7 %) 8 (15.7 %)
IB 5 (8.1 %) 9 (17.6 %)
IIA 7 (11.3 %) 10 (19.6 %)
IIB 12 (19.4 %) 11 (21.6 %)
IIIA 17 (27.4 %) 7 (13.7 %)
IIIB 10 (16.1 %) 5 (9.8 %)
IIIC 3 (4.8 %) 1 (2.0 %)
IV 2 (3.2 %) 0 (0 %)
Postoperative chemotherapy 42 (67.7 %) 28 (54.9 %) 0.162
Postoperative chemotherapy +
radiotherapy
19 (30.6 %) 11 (21.6 %) 0.277
ME McKeown esophagectomy, TE thoracolaparoscopic esophagectomy, T
tumor, Tis tumor in situ, N node, M metastasis, LN lymph node, mD medium
diameter, G grade
*p < 0.05; #p < 0.0001
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dissected and cut after the two ends were clamped by
Hemolok. The esophagus was dissected completely from
top to bottom. All lymph nodes in the operative field
were moved, including lymph nodes of recurrent laryn-
geal nerve chains (Fig. 1d), paraesophageal, paratracheal,
and subcarinal (Fig. 1e). The right chest was closed after
a 28 F chest drain was placed through the port 1# and a
negative pressure ball place through port 4#. Then, the
patient was changed to supine position with the head
moving right side to expose the left neck. One 12-mm
incision was made under navel for observation port
(Fig. 1b(1#); artificial pneumoperitoneum was per-
formed, 12 mmHg); four 5-mm operative ports under
subxiphoid (Fig. 1b(3#) enlarged later), right midclavicu-
lar line subcostal (Fig. 1b(4#)), left anterior axillary line
(Fig. 1b(2#)), and parasternal line 2 cm above navel
(Fig. 1b(5#)) were made. Ultrasonic scalpel was used to
dissect gastric greater and lesser curvature; the left gas-
tric artery and vein were cut off with two ends clamped
by Hemolok. The 3# port under subxiphoid was length-
ened to 5 cm, and a 5-cm pipe type gastric was tailored
by 75-mm stapler (America Johnson company) from this
port. Incision over the front of left sternocleidomastoid
muscle was performed and cervical esophagus was iso-
lated. A circular stapler was used to complete cervical
esophagogastrostomy.
The postoperative adjuvant chemotherapy was recom-
mended for the patients with advance tumor stage (more
than IIB stage). Chemotherapy regimen included Taxol
135 mg/m2 on day 1 and cis-platinum 75 mg/m2 on day
1. At least four chemotherapy cycles and 21 days as one
cycle was recommended. Postoperative radiotherapy is
performed when the surgical margin is positive and
when there were certain risk factors, such as depth of
tumor invasion, lymphovascular invasion, and paratra-
cheal lymph node involvement.
Statistical analysis
Mann–Whitney U and Pearson’s χ2 tests were performed
to test the difference between two groups. The statistical
analysis was completed in SPSS® version 19 (SPSS, Inc.,
Chicago, IL, USA), with p < 0.05 indicating a statistically
Fig. 1 a The incisions were made on the right later chest; a negative drainage ball was placed through the 4# port. b The incisions were made
on abdomen; a negative drainage ball was placed through the 2# port. c The histo-pathological type of EC was squamous cell cancer. d The
lymph nodes along the RLN were dissected. e The subcarinal lymph nodes were dissected. f One patient suffered pulmonary thrombosis because
of DVT, and died in-hospital; in the CT scan, a large embolus was found in the right pulmonary artery trunk
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significant difference. Overall and disease-free survival
were analyzed by the Kaplan–Meier method calculated




The demographics and operative data of the two groups
were described in Tables 2 and 3. The TE and ME groups
were matched for age, sex, personal hobbies (alcohol and
smoke), preoperative pulmonary function, blood gas ana-
lysis, American society of Anesthesiologist score, comor-
bidities, and blood routine test, except the BMI. The BMI
in TE group was significantly lower than that in ME group.
Surgical outcomes
In all patients, digestive tract reconstruction was
performed by stapled anastomosis with sleeve gastric
pull-up in an orthotopic position. In TE group, one pa-
tient converted to open surgery because of adhesion in
the right chest cavity. Compared with the ME group, the
TE group had a greater overall and thoracic operation
time (p = 0.006 and p = 0.034, respectively) and lesser
duration of stay in the intensive care unit and in-hospital
(p < 0.0001 and p = 0.007, respectively). The amount of in-
traoperative blood loss and the incidence of intraoperative
blood transfusion were greater in ME group. The drainage
of thoracic in ME group was more than that in TE group
on POD 1. More pulmonary complications were found in
ME group (p = 0.035). The expenditure in group TE was
higher attributing to the application of endoscopy device.
The data is shown in Table 3.
In-hospital outcomes
There was only one death in ME group (postoperative
day 3) from pulmonary embolism because of deep vein
Table 2 Patients demographies
ME group (n = 62) TE group (n = 51) p
Age 65.9 ± 6.5 64.5 ± 5.8 0.234
Gender (male/female) 42/20 36/15 0.745
Body mass index (BMI) 25.3 ± 4.6 22.5 ± 5.3 0.003*
Blood gas analysis
PO2 81.6 ± 7.6 82.6 ± 8.3 0.506
1PCO2 36.4 ± 7.2 35.8 ± 8.6 0.687
Pulmonary function
Vital capacity % 88.7 ± 13.6 86.9 ± 14.7 0.501
FEV1 % 79.4 ± 4.2 80.8 ± 5.3 0.120
Blood routine test
White blood cell (102/mm3) 57.5 ± 10.8 60.5 ± 11.4 0.155
Neutrophil (%) 71.5 ± 7.8 72.6 ± 8.5 0.475
Hemoglobin (g/L) 121.5 ± 19.4 119.4 ± 22.7 0.597
Albumin (g/L) 34.5 ± 4.3 33.9 ± 4.6 0.476
History of smoke 35 (56.5 %) 26 (51.0 %) 0.561
History of ethanol 23 (37.1 %) 12 (23.5 %) 0.121
Prior gastric or esophageal surgery 2 (3.2 %) 0 (0 %) 0.196
Previous chest surgery 1 (1.6 %) 0 (0 %) 0.362
Comorbidities
Coronary artery disease 5 (8.1 %) 2 (3.9 %) 0.363
Diabetes mellitus 6 (9.7 %) 7 (13.7 %) 0.502
COPD/emphysema 4 (6.5 %) 1 (2.0 %) 0.248
ASA grade 0.793
I 12 (19.4 %) 11 (21.6 %)
II 40 (64.5 %) 34 (66.7 %)
III 10 (16.1 %) 6 (11.8 %)
ME McKeown esophagectomy, TE thoracolaparoscopic esophagectomy, PO2 partial pressure of oxygen, PCO2 partial pressure of carbon dioxide, FEV1 forced
expiratory volume in 1 s, COPD chronic obstructive pulmonary disease, ASA American Society Of Anesthesiologists
*p < 0.05
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thrombosis (DVT) leading to respiratory compromise
(confirmed by computer tomography angiography Fig. 1f).
The rate of anastomostic leak was not significantly differ-
ent between the groups (2 vs. 1 patients, p = 0.677); all of
them were recovered by non-surgery management. Com-
plications according to the Clavien–Dindo classification
were reported in 48 patients (42.5 %); the majority
(68.7 %) of these was minor complications (grade I or II).
A total of 15 patients had a major complication (grade III
or IV). There was no statistically significant difference in
the rate of major complications between two groups (10
vs. 5, p = 0.324). The data is shown in Table 4.
The inflammatory response was lighter in TE group
than that in ME group. Patients in ME group have
significantly higher body temperature on POD 1 and
2, faster heart rate on POD 1, 2, and 3, more white
blood cell on POD 1, 2, and 3, faster respiratory rate
on POD 0 and 1, higher blood level of C-reactive
protein (CRP) on POD 0, 1, and 2, worse oxygenation
index (OI) on POD 0, 1, 2, and 3, and more obvious
incision pain on POD 0, 1, 2, and 3. The data is
shown on Table 5 and Figs. 2 and 3.
Pre- and postoperative pathologic parameters
The TNM stage difference between two groups is shown
in Table 1. In preoperative tumor staging, T2 (27.4 %)
and T3 (38 %) were detected in ME group, while T1
(29.4 %) and T2 (49 %) were detected in TE group
(p < 0.0001), which was similar in postoperative tumor
staging (p = 0.001). However, both in ME and TE
group, there was no significant difference between
pre- and postoperative T staging (p > 0.05), respectively.
Preoperatively, more lymph nodes were found in ME
group from the CT scan, but more lymph nodes were re-
moved in TE group; there was no significant difference on
mean positive nodes between two groups. There was no
difference on the tumor morphology and differentiation
degree between two groups. There was no significant dif-
ference on the postoperative adjuvant therapy between
two groups (Table 1).
Survival and medium-term outcomes
The median follow-up was 48 months (range 30–
60 months, ME 52 months vs. TE 44 months). No
significant difference was found between two groups on
overall survival (Fig. 4a, log–rank test: p = 0.193) or
Table 3 Operative outcomes data
ME group (n = 62) TE group (n = 51) p
Operation time (min) 252.6 ± 25.8 268.5 ± 34.5 0.006*
Thoracic surgery time (min) 61.2 ± 16.8 69.4 ± 23.6 0.034*
Intraoperative Blood loss (ml) 266.5 ± 98.5 211.8 ± 85.7 0.002*
Blood transfusion (%) 16 (25.8 %) 5 (9.8 %) 0.030
Drainage POD1 (ml) 357.6 ± 102.5 218.5 ± 95.9 <0.0001**
Pulmonary complications (total) 11 (17.7 %) 2 (3.9 %) 0.035
Reintubation 3 (4.8 %) 0 (0 %) 0.111
ICU stay (h) 22.1 ± 5.6 15.7 ± 6.5 <0.0001**
In-hospital stay (days) 15.6 ± 6.8 12.5 ± 4.8 0.007*
In-hospital stay mortality (%) 1 (1.6 %) 0 (0 %) 0.362
Hospitalization cost (dollar) 4856 ± 1255 6583 ± 1643 <0.0001*
ME McKeown esophagectomy, TE thoracolaparoscopic esophagectomy, POD1 first day postoperative day, ICU intensive care unit
*p < 0.05; **p < 0.0001
Table 4 Postoperative complications of thoracolaparoscopic
esophagectomy (TE) compared with open Mckeown
esophagectomy (ME)
Complications ME TE p
Clavien–Dindo grade
Minor
1 Urinary retention 2 1 0.677
Hypokalemia 2 3 0.400
2 Atrial fibrillation 8 1 0.033*
Pulmonary complications 5 1 0.150
Wound infection 1 0 0.362
Recurrent nerve injury 4 1 0.248
Chyle leak 3 1 0.410
Major
3 Pulmonary complications 3 1 0.410
Chyle leak 2 1 0.677
Anastomotic leak 1 1 0.889
Myocardial infarction 0 1 0.268
4 Pulmonary complications ARDS 2 0 0.196
Necrosis of gastric tube 0 1 0.268
Anastomotic leak 1 0 0.362
5 (death) DVT/pulmonary embolism 1 0 0.362
ME McKeown esophagectomy, TE thoracolaparoscopic esophagectomy, DVT
deep vein thrombosis
*p < 0.05
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disease-free survival (Fig. 4b, log–rank test: p = 0.065). A
total of 52 patients (46 %) died during follow-up (ME 32
vs. TE 20). Disease recurrence was observed in 61 pa-
tients (54 %) in 5 years, and there was no statistical dif-
ference between two groups.
Discussion
McKeown esophagectomy was the main surgical ap-
proach for the middle esophageal cancer nowadays in
China. ME had the advantage of reducing local recur-
rence and easier to manage if anastomosis leak occur in
the neck; however, the trauma caused by ME was great
and the postoperative complications happens frequently
[6]. With the development of the laparoscopy and
thoracoscopy technology, combined thoracolaparoscopic
esophagectomy for esophageal cancer was increasingly
adopted by thoracic surgeons. Theoretically, TE could
offer the potential advantages of rapid recovery, alleviating
of incision pain, and restore to normal function promptly;
however, the postoperative outcomes were controversial
[16]. The data of 51 patients undergoing TE in our depart-
ment were collected and analyzed. The postoperative out-
comes were compared carefully between two groups,
which especially included the postoperative complications,
Systemic Inflammatory Response Syndrome (SIRS), and
incision pain.
The surgery time of TE was significantly longer than
that of the ME group both in overall and thoracic oper-
ation. This result was consistent with several previous
studies [17, 18]. But Sundaram et al. [19] reported that
the operative time of TE was significantly shorter than
that of conventional transthoracic esophagectomy. TE is
a technically advanced surgical procedure which needs a
relatively longer learning curve. It has been reported that
a minimum of 17 cases were necessary to acquire TE
skills, and more than 35 cases were needed to achieve an
outcomes difference [20, 21]. Most of the patients in
TE group were in the beginning of the learning curve.
So, the surgical time was determined by surgeon’s
Table 5 Postoperative inflammation, oxygenation index, and
pain score compared between two groups
ME group (n = 62) TE group (n = 51) p
Body temperature (°C)
Pre 36.7 ± 0.4 36.6 ± 0.5 0.240
Post 38.2 ± 0.7 38.1 ± 0.8 0.480
POD 1 38.3 ± 0.8 37.8 ± 0.7 0.0007**
POD 2 37.5 ± 0.6 37.1 ± 0.4 0.0001**
POD 3 37.1 ± 0.5 36.9 ± 0.6 0.056
POD 5 36.6 ± 0.6 36.8 ± 0.5 0.060
Heart rate (bpm)
Pre 76.8 ± 8.4 78.6 ± 9.6 0.290
Post 88.4 ± 7.8 86.5 ± 8.4 0.216
POD 1 106.4 ± 7.4 98.7 ± 8.4 <0.0001#
POD 2 99.7 ± 8.5 95.8 ± 7.5 0.012*
POD 3 92.4 ± 6.8 88.9 ± 7.6 0.011*
POD 5 82.9 ± 8.4 80.7 ± 9.5 0.194
White blood cell (×109/L)
Pre 5.5 ± 1.1 5.6 ± 1.2 0.645
Post 8.8 ± 2.1 8.7 ± 1.8 0.789
POD 1 10.6 ± 1.4 9.8 ± 1.4 0.003*
POD 2 11.1 ± 1.3 10.4 ± 1.5 0.009*
POD 3 12.2 ± 1.2 11.5 ± 1.1 0.002*
POD 5 10.1 ± 0.9 9.8 ± 1.2 0.132
Respiratory rate (t/m)
Pre 15.4 ± 2.6 15.6 ± 2.8 0.695
Post 20.6 ± 3.2 18.5 ± 2.8 0.0004**
POD 1 19.4 ± 2.4 17.9 ± 2.5 0.0016*
POD 2 18.7 ± 3.5 17.5 ± 3.2 0.062
POD 3 18.6 ± 3.1 17.5 ± 2.9 0.056
POD 5 17.3 ± 1.9 16.9 ± 2.2 0.302
C-reactive protein (mg/L)
Pre 7.2 ± 3.1 6.8 ± 2.5 0.459
Post 13.4 ± 2.4 11.5 ± 1.8 <0.0001#
POD 1 14.8 ± 1.3 12.5 ± 2.1 <0.0001#
POD 2 13.5 ± 1.5 11.5 ± 1.7 <0.0001#
POD 3 11.5 ± 1.6 11.6 ± 1.5 0.735
POD 5 10.2 ± 1.9 10.7 ± 2.1 0.187
Oxygenation index (PO2/FiO2)
Pre 356.5 ± 32.2 361.2 ± 31.5 0.437
Post 327.6 ± 28.6 338.4 ± 26.8 0.042*
POD 1 318.6 ± 31.6 345.6 ± 28.9 <0.0001#
POD 2 328.8 ± 29.6 342.6 ± 34.3 0.023*
POD 3 331.5 ± 31.7 351.6 ± 29.5 0.001*
POD 5 348.8 ± 32.8 358.4 ± 31.5 0.118
Table 5 Postoperative inflammation, oxygenation index, and
pain score compared between two groups (Continued)
Pain score
Post 6.2 ± 0.5 5.5 ± 0.6 <0.0001#
POD 1 5.5 ± 0.6 3.6 ± 1.2 <0.0001#
POD 2 3.3 ± 0.4 3.0 ± 0.7 0.005*
POD 3 3.1 ± 0.6 2.7 ± 0.8 0.003*
POD 5 1.8 ± 0.5 1.6 ± 0.7 0.079
ME McKeown esophagectomy, TE thoracolaparoscopic esophagectomy, pre
preoperative, Post postoperative, POD postoperative day, bpm beats per
minute, t/m times per minute, PO2 partial pressure of oxygen, FiO2 fraction of
inspired oxygen
*p < 0.05; **p <0.001
#p <0.0001
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proficiency. Less blood loss and transfusion were ob-
served in TE group which was also found in series
researches [17–19]. Good visualization of the surgical
field during TE may ensure hemostasis and thus con-
tribute to reducing the blood loss.
Whether TE could achieve equivalent or superior on-
cologic outcomes with ME, two aspects included en bloc
tumor resection and field of lymphadenectomy. In this
study, no positive margin of esophagus was detected in
both groups, which indicated that the tumor can be re-
moved completely by both two approaches. However,
the number of retrieved lymph nodes in TE group was
significantly greater than that in group ME (17.8 ± 3.6 vs.
15.3 ± 3.2, p = 0.0002). The view of the surgical field
under TE was magnified which contribute the more re-
trieved lymph nodes. Positive lymph node along the
right recurrent laryngeal nerve (RLN) was found in 15
patients (11 in TE group and 4 in ME group); this may
attribute to the more lymph nodes retrieved along recur-
rent laryngeal nerve. Under the thoracoscopy, the recur-
rent laryngeal nerve can be dissected and protected
carefully. Four patients in ME and one patient in TE
have RLN palsy. The only one patient in TE group with
RLN palsy attributed to the RLN enwrapped by cancer,
and the RLN was injured by the high thermal energy of
ultrasonic scalpel. All of the nerve injury was temporary,
and the laryngeal function gradually returned to normal
in few weeks. However, not all the surgical team encoun-
tered the same condition. Schoppmann and Ben-David
[22, 23] reported the converse results.
In this study, more patients in ME group was in ad-
vanced TNM stage. This is an inherent limitation of the
retrospective study. The patients undergoing combined
thoracoscopic and laparoscopic surgery were selected
strictly. Patients in both groups received barium swallow
X-ray examination, esophagogastroduodenoscopy with
biopsy, and chest and abdominal computed tomography
to estimate the preoperative tumor TNM stage. In our
department, the selected patients for TE were usually
without serious comorbidities, and the esophageal tumor
stage (T stage) of them was much earlier when com-
pared with ME group (p < 0.001).
Preoperative tumor stage (T stage) was mainly ap-
praised by endoscopic ultrasonography (EUS). EUS
can provide information on invasive depth of EC (T
stage) and locoregional lymphadenopathy (N stage)
[24, 25]; however, recently prospective research re-
vealed that EUS was limited on resectability and the
authors suggested that it should not be performed in
all patients before surgery [26]. The patients with EC
in our department were received EUS examination
before surgery. In this cohort study, the preoperative
T stage evaluated by EUS was comparable with the
postoperative T stage (p > 0.05). We thought that EUS
Fig. 2 Square (black square) represents the ME group; triangle (black triangle) represents the TE group. *p < 0.05; #p < 0.0001. a The number of
white blood cell was compared between two groups in pre and 5 days after operation: the number of WBC was significantly less on POD 1, 2,
and 3 in TE group. b The body temperature was compared between two groups: the temperature was lower on POD 1 and 2 in TE group. c The
respiratory rate was compared between two groups: the RR was less on POD 0 and 1 in TE group. d The heart rate was compared between two
groups: the HR was faster on POD 1, 2, and 3 in ME group
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was a useful method for the accurate staging of
esophageal cancer before surgery.
Postoperative AF can result in hemodynamic comprom-
ise, thromboembolic phenomena, and anxiety. Other
sequelae include prolonged length of stay (LoS) and
increased cost. Several studies [27–29] indicated that
AF after esophagectomy was associated with postoperative
inflammatory response, pulmonary complications, surgical
Fig. 3 Square (black square) represents the ME group; triangle (black triangle) represents the TE group. *p < 0.05; #p < 0.0001. a The C-reactive
protein was compared between two groups: the CRP level in blood was significantly lower on POD 0, 1, and 2 in TE group. b The oxygenation
index was compared between two groups: the OI was better on POD 0, 1, 2, and 3 in TE group. c The degree incision pain was compared
between two groups: the pain was less on POD 0, 1, 2, and 3 in TE group
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trauma, hypoxia, incision pain, and damage of sympatho-
vagal nerve fibers supplying heart. Previous published pa-
pers [27, 28] try to elucidate the relation between AF and
anastomotic leak; however, there is no determination of
whether AF is caused by leak or, conversely, leak is caused
by AF with low cardiac output [30]. In this study, the re-
sults did not allow to explicit the relation between them.
Three patients suffered with anastomotic leak (occurred
on POD 4, 5, and 7, respectively); two of them have new
onset AF on POD2 and last for 2 and 4 days, respectively.
The cervical gastroesophageal anastomosis was performed
in all patients in this study, even if the leak happened; the
digestive juice can be drained from the cervical incision
without effect on thoracic cavity.
However, the relation between AF and pulmonary
complication was strong. All nine patients with AF
had pulmonary complications in varying degrees. The
results were consistent with previously published series
[27, 28, 31, 10]. More patients with AF and pulmonary
complication was found in ME group when compared
with TE group (8 vs. 1, p = 0.033; 11 vs. 2, p = 0.035). The
pulmonary complications were mainly pneumonia and
hypoxia (oxygenation index lower than 300). Postoperative
pneumonia happened frequently after open esophagec-
tomy. These kinds of patients usually present with cough,
expectoration, fever, wheezy phlegm by auscultation, and
lower SpO2. Re-intubation was performed on three pa-
tients with pneumonia in ME group who could not ex-
crete the phlegm. Minimal invasive esophagectomy offers
the advantage of alleviating the incision pain and promot-
ing earlier expectoration.
Open esophagectomy can cause obvious inflamma-
tory response, leading to the postoperative complication,
minimal invasive esophagectomy can attenuate SIRS [32,
33]. SIRS consist of four simple and clinical common used
indicators, which were used to evaluate the severity of
surgical stress [32, 34]. In this study, we found that the in-
cidence of SIRS in TE group was decreased. The more
trauma caused by operation and the more severe inflam-
matory response happened. Operative trauma can activate
the inflammatory cell following releasing some pro-
inflammatory cytokines which lead to a series postopera-
tive complications. One of effective methods to attenuate
SIRS was to decrease operative trauma. Minimal invasive
esophagectomy such as TE has the advantage of minimal
injury, less blood loss, less blood transfusion, less incision
pain, which alleviate the surgical stress.
Postoperative incision pain is a common phenomenon
in both surgical approaches. In this study, the patients in
ME group suffered greater incision pain until POD5.
This result was consistent with the report by Borro et al.
[35], which was that the incision pain caused by surgery
just lasted for 4 days. The incision pain was closed asso-
ciated with postoperative complications. Many patients
in ME group complained that they dared not coughing
because of incision pain, which contributed to the pneu-
monia, atelectasis. Incision pain could also induce tachy-
cardia, which was also a cause of AF.
Limitation of the study
The main limitation was the prospective study, and case
capacity was not large enough. As to the technique of
thoracolaparoscopic esophagectomy was performed
since April 2010, at the beginning, the patients with
lower BMI and earlier tumor stage were selected in min-
imal invasive group. All these led to the bias. Nowadays,
Fig. 4 Solid line (—) represents the TE group; dotted line (—) represents the ME group. a The overall survival rate was compared between two
groups (log–rank test: p = 0.193). b The disease-free survival rate was compared between two groups (log–rank test: p = 0.065)
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more patients with great BMI and advanced stage were
treated by thoracolaparoscopic esophagectomy. Furtherly,
new prospective randomized controlled trials are needed
to validate the results.
Conclusions
In this cohort study, although it is lack of randomness in
this research, SIRS of the patients in TE group was
lighter, and TE approach could alleviate the postopera-
tive incision pain, both contribute to better oxygenation
index after operation and lower postoperative pulmonary
complications. AF happened less in TE group probably
because of lighter inflammatory response, less pulmon-
ary complications, less incision pain, and better OI. The
survival was similar between two groups. The efficacy
and safety of TE were supported by these selected
patients.
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